Paperonium

Immunology · eLife · 2021

The paper’s summary: Fas ligand’s grip is 60 times weaker than TRAIL’s. Its measurements: 2 times.

The paper’s summaryweakerIts own measurementsweaker: 1.23 ÷ 0.60160×2.05×1×5×10×20×50×100×equally strong grip
The paper’ssummaryweakerIts ownmeasurementsweaker: 1.23÷ 0.60160×2.05×1×5×20×100×equally strong grip

How many times more weakly Fas ligand grips DR5 than TRAIL does

The paper says

The paper argues that a free-floating protein, Fas ligand, drives a kind of arthritis by latching onto DR5, a docking protein on the surface of cells. Its summary says Fas ligand grips DR5 about 60 times more weakly than TRAIL, DR5’s usual partner protein.

Its own data show

Grip is measured as how much protein it takes to occupy half the DR5 molecules; less needed means a tighter grip. The paper’s results give both, in trillionths of a mole per litre: Fas ligand 1.23, TRAIL 0.601 (printed 6.01 × 10⁻¹³). Fas ligand needs 1.23 ÷ 0.601 = 2.05 times as much.

The summary is the part most readers see. It casts Fas ligand as a far weaker partner for DR5 than TRAIL; by the paper’s own measurements the two are close. How much weaker matters for whether Fas ligand can act on DR5 in an inflamed joint, where TRAIL could compete for it. No measurement in the paper gives 60.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2 · eLife (2021) · doi:10.7554/eLife.48840